Apply This IPO

Best Margin

Zero Brokerage

24*7 Customer Support.

Fastest mobile support

---

Apply with Angel One

Apply with Zerodha

Pre-Apply with Upstox

GPT Healthcare Limited IPO Review

GPT Healthcare Limited engaged in a leading healthcare company in Eastern India with a significant presence in terms of hospital beds and facilities as of Fiscal Year 2023. Their brand runs a network of medium-sized hospitals offering comprehensive healthcare services, specializing in advanced medical care. They manage four multi-specialty hospitals located in Dum Dum, Salt Lake, and Howrah in West Bengal.

GPT healthcare ltd Competitive Strengths are Key regional corporate healthcare company with a strong foothold in under-penetrated and densely populated healthcare delivery markets, Well diversified specialty mix and location mix, Ability to attract, train and retain quality medical professionals, Track record of operating and financial performance and growth, Professional management and experienced leadership, Their Strategies are Strengthen their existing hospitals and their offerings and add new capabilities and specialties, Strategically grow their presence in adjacent markets, Focus on flexible and asset-light expansion for quick break-even, They have a specialized purchasing team that handles the centralized procurement of supplies, including medications, and equipment for all their hospitals. This department assesses vendors based on various factors like delivery reliability, product quality, pricing terms, and discounts, among others, before presenting a vendor list to the executive director for approval.

GPT Healthcare Limited Products and Services

GPT healthcare limited offer a wide range of healthcare services covering more than 35 specialties and advanced fields, such as internal medicine, diabetes care, kidney diseases (including kidney transplants), minimally invasive surgery, women's health, critical care, digestive disorders, bone and joint treatments, heart interventions, brain and nerve care, children's health, and newborn care. Additionally, each of their hospitals includes diagnostic facilities and pharmacies to serve their patients' needs.

Their hospitals have top-notch medical equipment and follow procedures and guidelines to ensure they deliver high-quality healthcare to their patients. They are committed to enhancing their technological resources, providing ongoing training for their medical staff, improving their daily operations, and exploring innovative methods to connect with and retain patients. For instance, they’re creating a mobile app called ILS-My Health to streamline patient care, scheduled to debut in Fiscal Year 2024.

Financial Overview

In terms of financial performance over the past three fiscal years, the company has recorded total earnings and net profits as follows: Rs. 248.86 crore / Rs. 21.09 crore (FY21), Rs. 342.40 crore / Rs. 41.66 crore (FY22), and Rs. 366.73 crore / Rs. 39.01 crore (FY23). The company is a healthcare related service provider in the eastern region. The company saw an increase in its revenue, but its profits were inconsistent, especially with a decline in net profit for FY23. Considering the strong earnings projected for FY24, the stock seems to be adequately valued. Investors who are well-informed might opt to invest a moderate amount for the medium term in this dividend-paying company.